Nexentis subsidiary MitoCareX expands bioinformatics for drug discovery

MitoCareX adds an expert bioinformatician to expand disease-pathway analysis capabilities. New bioinformatics layer integrates with existing structural modeling and virtual screening tools. Expansion builds on recent deployment of computational infrastructure on Google Cloud Platform. Goal is to evaluate potential targets within broader disease biology context earlier in discovery.